Hemophilia B

The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.

The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.

The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.

The FDA has approved a drug for the treatment of patients with with locally advanced or metastatic urothelial carcinoma.

The FDA has approved a drug for the treatment of patients with with locally advanced or metastatic urothelial carcinoma.

The FDA has approved a drug for the treatment of patients with with locally advanced or metastatic urothelial carcinoma.

The first combination pack for the treatment of advanced or metastatic breast cancer in postmenopausal women has been approved by the FDA.

The first combination pack for the treatment of advanced or metastatic breast cancer in postmenopausal women has been approved by the FDA.

The first combination pack for the treatment of advanced or metastatic breast cancer in postmenopausal women has been approved by the FDA.

A new treatment for amyotrophic lateral sclerosis, also known as Lou Gehrig disease, was recently approved by the US Food and Drug Administration.